AI Article Synopsis
- * Initial testing on military veterans indicated that CAPS-5 demonstrates strong reliability and validity, effectively diagnosing PTSD and measuring symptom severity.
- * The findings show that CAPS-5 maintains strong consistency with the previous version, CAPS-IV, ensuring continuity in PTSD assessment methods.
Article Abstract
The Clinician-Administered PTSD Scale (CAPS) is an extensively validated and widely used structured diagnostic interview for posttraumatic stress disorder (PTSD). The CAPS was recently revised to correspond with PTSD criteria in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric Association, 2013). This article describes the development of the CAPS for DSM-5 (CAPS-5) and presents the results of an initial psychometric evaluation of CAPS-5 scores in 2 samples of military veterans (Ns = 165 and 207). CAPS-5 diagnosis demonstrated strong interrater reliability (к = .78 to 1.00, depending on the scoring rule) and test-retest reliability (к = .83), as well as strong correspondence with a diagnosis based on the CAPS for DSM-IV (CAPS-IV; к = .84 when optimally calibrated). CAPS-5 total severity score demonstrated high internal consistency (α = .88) and interrater reliability (ICC = .91) and good test-retest reliability (ICC = .78). It also demonstrated good convergent validity with total severity score on the CAPS-IV (r = .83) and PTSD Checklist for DSM-5 (r = .66) and good discriminant validity with measures of anxiety, depression, somatization, functional impairment, psychopathy, and alcohol abuse (rs = .02 to .54). Overall, these results indicate that the CAPS-5 is a psychometrically sound measure of DSM-5 PTSD diagnosis and symptom severity. Importantly, the CAPS-5 strongly corresponds with the CAPS-IV, which suggests that backward compatibility with the CAPS-IV was maintained and that the CAPS-5 provides continuity in evidence-based assessment of PTSD in the transition from DSM-IV to DSM-5 criteria. (PsycINFO Database Record
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805662 | PMC |
| http://dx.doi.org/10.1037/pas0000486 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial.
JAMA Psychiatry
December 2024
Otsuka Pharmaceutical Development & Commercialization Inc, Princeton, New Jersey.
Importance: New pharmacotherapy options are needed for posttraumatic stress disorder (PTSD).
Objective: To investigate the efficacy, safety, and tolerability of brexpiprazole and sertraline combination treatment (brexpiprazole + sertraline) compared with sertraline + placebo for PTSD.
Design, Setting, And Participants: This was a parallel-design, double-blind, randomized clinical trial conducted from October 2019 to August 2023.
Trauma-related moderators of associations between sex hormones and PTSD symptoms: a replication-extension.
Eur J Psychotraumatol
December 2024
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Post-traumatic stress disorder (PTSD) disproportionately affects women and recent evidence suggests that unique associations between sex hormones (e.g. estradiol and progesterone) and PTSD symptoms may contribute to this difference.
View Article and Find Full Text PDFNeurobiological response to trauma-related and general negative words in men firefighters with post-traumatic stress disorder, compared to trauma-exposed and trauma non-exposed controls: A pilot study.
Psychiatry Res Neuroimaging
December 2024
Department of Psychiatry, Chung-Ang University, School of Medicine, Republic of Korea. Electronic address:
Although firefighters frequently encounter various traumatic incidents, few develop posttraumatic stress disorder (PTSD). In this pilot study, we aimed to examine trauma-specific neurobiological alterations in firefighters with PTSD, distinguishing these characteristics from those of trauma-exposed controls. Twenty-two firefighters (11 firefighters with PTSD and 11 trauma-exposed controls) and 25 trauma non-exposed controls completed psychiatric questionnaires and functional magnetic resonance imaging while engaging in a trauma-specific emotional counting Stroop task for firefighters.
View Article and Find Full Text PDFNarrative exposure therapy for the treatment of trauma-related symptoms among adolescent survivors of sex trafficking: A pilot study.
Indian J Psychiatry
October 2024
Department of Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.
Background: India is home to 14 million survivors of human trafficking, with most being trafficked for sexual exploitation. Trafficking constitutes crimes that violate the rights of survivors, and despite its psychological consequences, there is little evidence-based guidance to meet the needs of these individuals.
Aim: The current study aimed to examine the outcome of narrative exposure therapy (KIDNET) among adolescent survivors of sex trafficking in improving trauma-related symptoms, along with psychological distress, dissociation, depression, and anxiety.
BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder.
NEJM Evid
December 2024
Department of Psychiatry and School of Public Health, University of California, San Diego, La Jolla.
Background: Post-traumatic stress disorder (PTSD) is a serious, debilitating, and prevalent psychiatric condition occurring in people who are traumatized and experience intense, disturbing thoughts and feelings that persist. BNC210 is a novel α7 nicotinic acetylcholine receptor-negative allosteric modulator developed to treat PTSD.
Methods: ATTUNE was a randomized, double-blind, phase 2b, placebo-controlled trial.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!